Predicted Trait | |
Reported Trait | Non-Hodgkin's lymphoma |
Mapped Trait(s) | non-Hodgkins lymphoma (EFO_0005952) |
Score Construction | |
PGS Name | CC_NHL_IV |
Development Method | |
Name | 19 variants from Graff et al (PGS000080) with inverse variant weights |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 19 |
Effect Weight Type | Inverse-variance weighting |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000186 |
Citation (link to publication) | Kachuri L et al. Nat Commun (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 85.3% Not Reported: 14.7% 34,043 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST002636 Europe PMC: 25261932 |
11,523 individuals | European | 23 cohorts
|
GWAS Catalog: GCST002643 Europe PMC: 25279986 |
10,486 individuals | European | 20 cohorts
|
GWAS Catalog: GCST001826 Europe PMC: 23349640 |
4,988 individuals | Not reported | DFHCC, HPFS, MSKCC, NHS |
GWAS Catalog: GCST002742 Europe PMC: 25569183 |
7,046 individuals | European | 22 cohorts
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM002062 | PSS001019| European Ancestry| 391,968 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident non-hodgkin's lymphoma | HR: 1.15 [1.08, 1.22] | AUROC: 0.677 C-index: 0.674 (0.01) |
R²: 0.227 | Age at assessment, sex, genotyping array, PCs(1-15) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001019 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [
|
— | European | — | UKB | — |